The primary purpose of the Dr. Charles A. Coltman, Jr., Fellowship is to engage outstanding young investigators from SWOG affiliated institutions in learning clinical trial methodology within an academic and cooperative group environment that will lead to independent clinical research, while honoring the legacy of long-time SWOG Chair and leader, Dr. Charles Coltman. To qualify, …
The Young Investigators Training Course is designed to intensively train selected young investigators in the SWOG system for protocol development, maintenance, and administration in order to develop a cadre of experts to quickly and efficiently develop priority studies. For the purposes of this training, young investigators are defined as oncology fellows in training or assistant …
We are pleased to report that The Hope Foundation has received notification of its continued Accreditation status from the Accreditation Council for Continuing Medical Education (ACCME). Staff members who worked diligently throughout the reaccreditation process are thrilled that Hope’s CME program has demonstrated compliance. We look forward to continuing to improve our educational programming to …
SWOG/Hope Foundation Impact Award (formerly The SWOG Development Award) The SWOG/Hope Foundation Impact Award is a funding program from The Hope Foundation that encourages novel and innovative SWOG research by supporting early and conceptual stages of these projects. It is expected that support via this mechanism will lead to subsequent extramural support from other sources, …
Soham Puvvada, M.D., assistant professor of medicine at the University of Arizona, has been awarded a Charles A. Coltman, Jr., Fellowship from The Hope Foundation. The funding will support her development of a phase III randomized clinical trial that will compare rituximab-chemotherapy induction plus maintenance rituximab with or without ibrutinib in patients with newly diagnosed …
The Development Awards fund novel research with potential to inform future SWOG trials. The review committee most recently convened to conduct thorough evaluations of eleven applications. Two awards were granted: Dr. Omar Aljitawi “Pilot study exploring the use of hyperbaric oxygen in autologous PBSC transplantation” Dr. Robert Doebele “Evaluation of crizotinib resistance mechanisms to predict …
Michael LeBlanc, PhD
Group Statistician
JOIN OUR EMAIL LIST
Johanna Horn, President & CEO
